Newspaper advertisement for unaudited Result for Quarter and Half year ended on September 30,2026

November 05,2026 BSE Limited N a tional Stock Exchange of India Limited Corporate Relationship Department. E x c h a nge Plaza, Plot No. C/1, G-Block PJ Towers, 25th Floor, B a n d r a Kurla Complex, Dalal Street, Mumbai- 400 001 B a n d ra (East), Mumbai- 400 051. BSE Scrip Code No. 543687 N S E S y m b o l : - DHARMAJ Dear Sir/Madam, Sub: -Newspaper Advertisement - Disclosure under Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed herewith the copies of advertisement published on November 05, 2026 in Financial Express English edition and Gujarati edition for Consolidated & Standalone Un-audited Financial Results for the Second quarter and Half Year ended on September 30, 2026. You are requested to kindly take the same on your record. Thanking you, For, Dharmaj Crop Guard Limited Malvika Bhadreshbhai Kapasi Company Secretary & Compliance Officer ACS52602 Encl.: As above PRERNA INFRABUILD LIMITED Reg. Office: 'PRERNA' Survey No 820/1, In Lane Of Zaveri Circle, S.G. Road, Ahmedabad - 380058. CIN: L65990GJ1988PLC010570 E-mail: info@prernagroup.com, Website: www.prernagroup.com PART-I: EXTRACT OF UNAUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30th SEPTEMBER, 2026 ( in lakhs) 3 Months Half Year Ended Year Ended on Sr. Particulars 30/09/2026 30/06/2026 30/09/2025 30/09/2026 30/09/2025 31/03/2026 No. (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) 1. Total Income From Operations 676.79 152.73 636.54 829.52 636.54 949.33 2. Net Profit/(Loss) for ordinary activities before Tax, 108.5 20.42 112.88 128.92 112.11 439.03 Exceptional) 3. Net Profit/(Loss) for the period before tax 87.41 13.17 94.9 100.58 86.33 352.69 (after Exceptional ) 4. Net Profit/(Loss) for the period after tax 99.24 34.12 93.71 133.36 89.68 323.59 (after Exceptional ) 5. Total Comprehensive Income for the Period 99.24 34.12 93.71 133.36 89.68 323.59 {Comprising Profit/Loss for the period (After Tax) and Other Comprehensive Income (After Tax)} 6. Equity Share Capital.(face value of Rs.10 each) 3612.75 3612.75 3612.75 3612.75 3612.75 3612.75 7. Reserves (excluding Revaluaton Reserve) as shown - - - - - 6635.39 in balance Sheet of previous 8. Earning Per Share (of' Rs.10/-each)- Not annualised Basic 0.27 0.09 0.26 0.37 0.25 0.90 Diluted 0.27 0.09 0.26 0.37 0.25 0.90 Note: The above is an extract of the detailed format of Quarterly and Year Ended Financial Results filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing and Other Disclosure Requirements) Regulations, 2015. The full format of the Quarterly / Half Year Ended Financial Results are available on the Stock Exchange website www.bseindia.com and on the Company’s website www.prernagroup.com. Part-II: Additional information of Standalone Audited financial Result is as under: ( in lakhs) 3 Months Half Year Ended Year Ended on Sr. Particulars 30/09/2026 30/06/2026 30/09/2025 30/09/2026 30/09/2025 31/03/2026 No. (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) 1. Total Income From Operations 257.00 152.73 336.96 409.73 338.96 452.96 2. Net Profit/(Loss) before Tax 122.37 39.32 111.69 161.69 115.46 409.93 3. Net Profit/(Loss) after Tax 101.28 32.07 93.71 133.35 89.68 323.59 For, Prerna Infrabuild Limited Sanket Shah, Managing Director Place : Ahmedabad Date : 04/11/2026 DIN: 00038121 Aarti Drugs Limited RegisteredOffice:PlotNo.N-198,MIDC,Tarapur,VillagePamtermbhi,Dist.Palghar-401506,Maharashtra CIN:L37060MH1984PLC055433EmailID:investorrelations@aartidrugs.comWebsite:www.aartidrugs.com STATEMENTOFAUDITEDFINANCIALRESULTSFORTHEQUARTERENDED30THSEPTEMBER,2026 (`InLacsexceptforEPS) Standalone Consolidated PARTICULARS QuarterEnded PeriodEnded YearEnded QuarterEnded PeriodEnded YearEnded 30.09.2026 30.06.202630.09.2025 30.09.2026 30.09.2025 31.03.2026 30.09.202630.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 (Audited) (Audited) (Audited) (Audited) (Audited) (Audited) (Audited) (Audited) (Audited) (Audited) (Audited) (Audited) Totalincome 70,893 62,765 57,910 133,658 110,044 226,298 82,879 70,359 65,288 153,238 124,370 256,770 Netprofitfortheperiod (beforetax,exceptionaland/orextraordinaryitems) 7,673 6,994 5,578 14,666 10,103 18,131 10,928 7,132 6,041 18,061 11,152 21,090 Exceptionalitems - 209 - 209 - - 209 - - 209 - - NetprofitfortheperiodafterTax (afterexceptionaland/orextraordinaryitems) 5,768 5,085 4,178 10,853 9,042 16,922 8,277 5,013 4,516 13,290 9,913 19,494 OtherComprehensiveIncome(aftertax) (27) - (27) - 247 (47) 6 (41) 11 320 TotalComprehensiveIncomefortheperiod 5,741 5,085 4,178 10,826 9,042 17,169 8,230 5,019 4,516 13,249 9,924 19,814 Weightedaveragenumberofequitysharesusedfor 9,127 9,127 9,127 9,127 9,127 9,127 9,127 9,127 9,127 9,127 9,127 9,127 computingearningpershare(facevalueofRs.10each) Earningpershare(inRs.)(notannualised) (a)Basic 6.32 5.57 4.58 11.89 9.91 18.54 9.07 5.49 4.95 14.56 10.86 21.36 (b)Diluted 6.32 5.57 4.58 11.89 9.91 18.54 9.07 5.49 4.95 14.56 10.86 21.36 Notes: 1 TheaboveresultsfortheQuarterended30thSeptember,2026havebeenreviewedbytheAuditCommitteeandapprovedbytheBoardofDirectorsintheirmeetingheldon3rdNovember,2026. 2 Ason30thSeptember,2026theCompany,has3(three)subsidiaries,namely,PinnacleLifeSciencePrivateLimited,AartiSpecialityChemicalsLimited,PinnacleChileSpAand2(two)stepdown subsidiary,namelyPharmaGoSpA,TripharmaChileSpA. 3 Exceptionalitemrepresentsthewrite-offofCapitalwork-in-Progress(CWIP)ofRs.2.09Cr.PertainingtotheadministrativebuildingsituatedatE1,asanroutineexpansionsplans. 4 Companyhasonlyonebusinesssegmenti.e.pharmaceuticals. 5 StatutoryAuditorshavecarriedoutauditoftheabovefinancialsresultsforthequarterended30thSeptember,2026andhaveexpressedunmodifiedauditopinion. 6 FiguresforthepreviousQuarterhavebeenregroupedorrearrangedwherevernecessary. 7 TheaforesaidAuditedFinancialResultsareavailableontheCompany'swebsitewww.aartidrugs.comandalsoonthewebsiteofBSELimitedwww.bseindia.comandtheNationalStockExchangeof IndiaLimitedwww.nseindia.comforthebenefitoftheshareholdersandinvestors.ThesamecanbeaccessedbyscanningtheQRcodeprovidedbelow: ForAartiDrugsLimited Sd/- AdhishP.Patil Place:Mumbai (ManagingDirector) Date:3rdNovember,2026 DIN:02629496